Uncertain role of high dose chemotherapy with autologous stem cell support in pediatric pleuro-pulmonary blastoma (PPB) 1997

A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D018202 Pulmonary Blastoma A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells (i.e., blast forms) with little or virtually no stroma. (From Stedman, 25th ed) Blastoma, Pulmonary,Blastomas, Pulmonary,Pulmonary Blastomas
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell

Related Publications

A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
May 2000, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
November 1997, Current opinion in hematology,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
December 1992, Oncology (Williston Park, N.Y.),
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
June 1999, Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
April 1996, Annals of medicine,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
January 2003, Journal of pediatric hematology/oncology,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
August 1998, Cancer treatment reviews,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
January 1999, Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
February 1998, Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel,
A N Békássy, and S Garwicz, and T Wiebe, and I Hagerstrand
December 1995, Cancer,
Copied contents to your clipboard!